Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Other financing activities (2023 - 2024)

Neurogene's Other financing activities history spans 2 years, with the latest figure at $4.3 million for Q4 2024.

  • For Q4 2024, Other financing activities rose 318.61% year-over-year to $4.3 million; the TTM value through Sep 2025 reached $4.3 million, up 318.61%, while the annual FY2024 figure was $4.3 million, N/A changed from the prior year.
  • Other financing activities reached $4.3 million in Q4 2024 per NGNE's latest filing, up from -$4.3 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $4.3 million in Q1 2024 to a low of -$4.3 million in Q3 2024.